Fox News chief correspondent Jonathan Hunt reports on the search for Nancy Guthrie and the latest updates from investigators on ‘Special Report.’ US judge throws out immigration board's ruling ...

“Why should only the tall have access to tall genes? And why should only the smart have access to smart genes?… our goal is to give as many people as possible the opportunity to choose their genes for ...

Mohana Ravindranath is a freelance health, science, and tech journalist and a 2025 Association for Health Care Journalists fellow. She was previously a Bay Area health tech correspondent for STAT. As ...

Deciphering gene circuits can be tedious and immensely time consuming. Modifying, or designing gene circuits from previously identified pathways presents further challenges. “There are many possible ...

Meta has now rolled out the "Build Your 2026 Algorithm" feature for Instagram Reels to allow users use it to personalize their feeds. Instagram Reels 'Build Your 2026 Algorithm' Now Live After a test ...

There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it takes for cells to behave in desired ways—for example, getting them to produce ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

A startup’s ads for controversial embryo tests hit the New York City subway. One day this fall, I watched an electronic sign outside the Broadway-Lafayette subway station in Manhattan switch ...

Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, Denmark, and Germany are developing a genetic test to predict which medications ...

On October 16, 2025, Governor Kathy Hochul signed into law S.7882, which amends New York’s antitrust law, the Donnelly Act, to prohibit the use of pricing algorithms by residential landlords to set ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...